Kaposiform HemangioendotheliomaSymptoms, Doctors, Treatments, Advances & More
Learn About Kaposiform Hemangioendothelioma
- Kaposiform Hemangioendothelioma
- Congenital cutaneous multifocal kaposiform hemangioendothelioma
- KH
- KHE
- Kaposiform hemangio-endothelioma
Avera Medical Group Dermatology — Mitchell
Mandi Greenway, MD, a dermatologist, provides expert skin care for people of all ages at Avera Medical Group Dermatology in Mitchell, SD. Dr. Greenway is rated as an Advanced provider by MediFind in the treatment of Kaposiform Hemangioendothelioma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Seborrheic Keratosis, and Melanoma. Dr. Greenway is board certified in American Board Of Dermatology.
Avera Dermatology — Pierre
Dr. Katie Bonnichsen, a dermatologist, provides expert skin care at Avera Medical Group located in the Helmsley Center at Avera St. Mary's Hospital in Pierre, SD. Dr. Bonnichsen is rated as an Advanced provider by MediFind in the treatment of Kaposiform Hemangioendothelioma. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Seborrheic Keratosis, Warts, and Kaposiform Hemangioendothelioma. Dr. Bonnichsen is board certified in Eligible - American Board Of Dermatology.
Avera Dermatology — Pierre
Dr. (Joyce) Wesley Fletcher is a dermatologist at Avera Medical Group in Pierre, located in the Helmsley Center at Avera St. Mary's Hospital. Dr. Fletcher is rated as an Advanced provider by MediFind in the treatment of Kaposiform Hemangioendothelioma. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, and Neurocutaneous Melanosis.
Summary: This randomized clinical trial evaluates if low-dose sirolimus (target trough 4-8 ng/mL) combined with prednisolone is noninferior in efficacy but superior in safety compared to standard high-dose sirolimus (target trough 10-15 ng/mL) combined with prednisolone in pediatric patients with kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon (KHE with KMP), with participants randomized 1:...
Summary: To research and explore the antibody protection and immune memory after vaccination in children with KHE during sirolimus administration. To explore the feasibility (safety and efficacy) of vaccination in a timely manner during the administration of sirolimus in children with KHE. To search for back-up plans for vaccination regimens for KHE patients taking sirolimus in children who do not respond ...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center